Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapport Therapeutics (RAPP) Free Cash Flow (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Free Cash Flow data on record, last reported at -$13.1 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 35.96% to -$13.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$80.7 million, a 16.84% decrease, with the full-year FY2025 number at -$88.1 million, down 31.02% from a year prior.
  • Free Cash Flow reached -$13.1 million in Q1 2026 per RAPP's latest filing, up from -$24.9 million in the prior quarter.
  • Over the last five years, Free Cash Flow for RAPP hit a ceiling of -$5.5 million in Q3 2023 and a floor of -$25.1 million in Q2 2025.
  • A 4-year average of -$16.9 million and a median of -$17.3 million in 2024 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: tumbled 202.32% in 2024, then skyrocketed 35.96% in 2026.
  • Tracing RAPP's Free Cash Flow over 4 years: stood at -$11.8 million in 2023, then decreased by 24.4% to -$14.7 million in 2024, then plummeted by 69.51% to -$24.9 million in 2025, then surged by 47.14% to -$13.1 million in 2026.
  • Business Quant data shows Free Cash Flow for RAPP at -$13.1 million in Q1 2026, -$24.9 million in Q4 2025, and -$17.6 million in Q3 2025.